• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS Back to Search Results
Device Problem Positioning Problem (3009)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/12/2020
Event Type  malfunction  
Event Description
(b)(6) clinical study.It was reported that the balloon over extended during inflation.In (b)(6) 2020, the index procedure was performed.The target lesion was in the right peroneal artery with 99% stenosis, proximal and distal reference vessel diameter was 3.25 mm and 3.0 mm respectively with a length of 60 mm.As a treatment, orbital atherectomy was performed.Post atherectomy, balloon angioplasty was attempted with sterling balloon but there was significant 'watermelon seeding' of the irregular balloon.The balloon was withdrawn and the lesion was treated with a 4.0 mm x 15 mm cutting balloon to pre-dilate the lesion at burst pressures with a 20% residual stenosis.Post pre-dilation, the lesion was further treated with placing a 3.5 mm x 80 mm study stent.Post dilation was performed with residual stenosis of 0%.
 
Event Description
Saval pivotal clinical study.It was reported that the balloon over extended during inflation.In (b)(6) 2020, the index procedure was performed.The target lesion was in the right peroneal artery with 99% stenosis, proximal and distal reference vessel diameter was 3.25 mm and 3.0 mm respectively with a length of 60 mm.As a treatment, orbital atherectomy was performed.Post atherectomy, balloon angioplasty was attempted with sterling balloon but there was significant 'watermelon seeding' of the irregular balloon.The balloon was withdrawn and the lesion was treated with a 4.0 mm x 15 mm cutting balloon to pre-dilate the lesion at burst pressures with a 20% residual stenosis.Post pre-dilation, the lesion was further treated with placing a 3.5 mm x 80 mm study stent.Post dilation was performed with residual stenosis of 0% it was further reported that prior treating the target lesion, the superficial femoral artery (non-target lesion) with 95% stenosis was treated with sterling balloon catheter.The orbital atherectomy was performed at low speed.A significant wire bias precluded failure speed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERLING
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10351162
MDR Text Key201526696
Report Number2134265-2020-10189
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 08/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received08/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age69 YR
-
-